Edlin Rachel S, Heyns Chris F, Van Vuuren Stephan P J, Zarrabi Amir D
Department of Urology, Stellenbosch University and Tygerberg Hospital, Tygerberg, Western Cape, South Africa.
S Afr J Surg. 2012 Nov 12;50(4):127-30. doi: 10.7196/sajs.1095.
To determine the prevalence of prostatitis on histopathological evaluation of prostatic tissue in men without urinary retention.
DESIGN, SETTING AND SUBJECTS: The clinical data and histopathology reports of men seen from January 1999 through March 2009 at our institution were analysed using Student's t-test, the Mann-Whitney test and Fisher's exact test where appropriate. Values were expressed as means, medians and ranges (p<0.05 accepted as statistically significant).
Data collected included patient age, duration of lower urinary tract symptoms and hospitalisation, findings on digital rectal examination, prostate volume, haemoglobin concentration, serum creatinine and prostate-specific antigen (PSA) levels, and histological findings.
Prostatic tissue of 385 men without urinary retention at presentation was obtained via biopsy (48.3% of cases), transurethral prostatectomy (62.9%), retropubic prostatectomy (6.8%) or radical prostatectomy (28.3%). On histological examination, benign prostatic hyperplasia (BPH) was found to be present in 213 patients (55.3%) and adenocarcinoma of the prostate (ACP) in 172 (44.7%). Histological prostatitis was present in 130 patients (61.0%) with BPH and 51 (29.7%) with ACP (p<0.001). A previous study of 405 men presenting with urinary retention at our institution showed histological prostatitis in 98/204 (48.0%) with BPH and in 51/201 (25.4%) with ACP. The group of men with BPH alone had a significantly lower mean serum PSA at presentation (4.5 ng/ml, range 0.3 - 20.8 ng/ml) compared with the group with BPH and prostatitis (11.2 ng/ml, range 0.2 - 145 ng/ml, p=0.011). The mean PSA level at presentation did not differ significantly between the group with ACP only (40.9 ng/ml, range 0 - 255 ng/ml) and the group with ACP plus prostatitis (1 672 ng/ml, range 0.3 - 38 169 ng/ml, p=0.076).
Among men presenting without urinary retention, histological prostatitis was significantly more prevalent in those with BPH than in those with ACP (61% v. 30%), similar to the previous study of men presenting with retention at our institution, in which histological prostatitis was significantly more prevalent in BPH than in ACP (48% v. 25%). This finding suggests that histological prostatitis is not significantly associated with the causation of ACP or urinary retention. Serum PSA at presentation was significantly higher in the group with BPH plus prostatitis compared with BPH alone, but not in the group with ACP plus prostatitis compared with ACP alone.
确定在无尿潴留男性的前列腺组织病理评估中前列腺炎的患病率。
设计、设置与研究对象:分析了1999年1月至2009年3月在本机构就诊男性的临床资料和组织病理学报告,在适当情况下使用了学生t检验、曼 - 惠特尼检验和费舍尔精确检验。数值以均值、中位数和范围表示(p<0.05被认为具有统计学意义)。
收集的数据包括患者年龄、下尿路症状持续时间和住院时间、直肠指检结果、前列腺体积、血红蛋白浓度、血清肌酐和前列腺特异性抗原(PSA)水平以及组织学检查结果。
385例初诊时无尿潴留男性的前列腺组织通过活检获取(48.3%的病例)、经尿道前列腺切除术(62.9%)、耻骨后前列腺切除术(6.8%)或根治性前列腺切除术(28.3%)。组织学检查发现,213例患者(55.3%)存在良性前列腺增生(BPH),172例(44.7%)存在前列腺腺癌(ACP)。130例BPH患者(61.0%)和51例ACP患者(29.7%)存在组织学前列腺炎(p<0.001)。此前对本机构405例有尿潴留男性的研究显示,204例BPH患者中有98例(48.0%)存在组织学前列腺炎,201例ACP患者中有51例(25.4%)存在。单纯BPH组初诊时的平均血清PSA水平(4.5 ng/ml,范围0.3 - 20.8 ng/ml)显著低于BPH合并前列腺炎组(11.2 ng/ml,范围0.2 - 145 ng/ml,p = 0.011)。单纯ACP组(40.9 ng/ml,范围0 - 255 ng/ml)和ACP合并前列腺炎组(1672 ng/ml,范围0.3 - 38169 ng/ml)初诊时的平均PSA水平差异无统计学意义(p = 0.076)。
在无尿潴留的男性中,BPH患者的组织学前列腺炎患病率显著高于ACP患者(61%对30%),这与我们机构此前对有尿潴留男性的研究结果相似,其中BPH患者的组织学前列腺炎患病率显著高于ACP患者(48%对25%)。这一发现表明组织学前列腺炎与ACP或尿潴留的病因无显著关联。BPH合并前列腺炎组初诊时的血清PSA显著高于单纯BPH组,但ACP合并前列腺炎组与单纯ACP组相比无显著差异。